摘要:
A method of forming a compound of formula (IV) comprising the step of reacting a compound of formula (III) with a 2-ethylhexanoate salt:
wherein R 1 in each occurrence is independently selected from H, halogen, amino, C 1-5 alkyl, C 2-5 alkenyl and C 2-5 alkynyl; R 2 in each occurrence is independently selected from H, halogen, amino, C 1-5 alkyl, C 2-5 alkenyl and C 2-5 alkynyl; and R 4 is C 1-5 alkyl; X- is an anion and each R 3 is independently selected from the group consisting of C 1-10 hydrocarbyl and C 1-5 alkoxy.
摘要:
Novel 2α-methyl-2β-[(1,2,3-triazol-1-yl)methyl]penam-3α-carboxylic acid benzhydryl ester (TMPB)-acetone crystals for use in producing 2α-methyl-2β-[(1,2,3-triazol-1-yl)methyl]penam-3α-carboxylic acid 1,1-dioxide benzhydryl ester (TAZB); a process for producing TMPB-acetone crystals which comprises (A) the step of concentrating an organic solvent solution containing TMPB, (B) the step of dissolving the resultant concentrate in acetone, and (C) the step of crystallizing TMPB-acetone crystals from the acetone solution obtained; and a process for producing TAZB which comprises the step of reacting TMPB-acetone crystals with an oxidizing agent.
摘要:
The crystal of the invention is crystal of diphenylmethyl 2-methyl-2-triazolylmethylpenam-3-carboxylate which is stable substantially without decomposition or degradation of properties even when left to stand at room temperature for 1 year. The crystal of the invention can be prepared by a process comprising the steps of concentrating a solution containing diphenylmethyl 2-methyl-2-triazolylmethylpenam-3-carboxylate represented by the formula (2) wherein Ph is a phenyl group, diluting the concentrate with acetic ester and mixing the diluted solution with hexane or a solvent mixture of hexane and acetic ester to crystallize the diphenylmethyl 2-methyl-2-triazolylmethylpenam-3-carboxylate.
摘要:
A method of forming a compound of formula (IV) comprising the step of reacting a compound of formula (III) with a 2-ethylhexanoate salt: wherein R 1 in each occurrence is independently selected from H, halogen, amino, C 1-5 alkyl, C 2-5 alkenyl and C 2-5 alkynyl; R 2 in each occurrence is independently selected from H, halogen, amino, C 1-5 alkyl, C 2-5 alkenyl and C 2-5 alkynyl; and R 4 is C 1-5 alkyl; X- is an anion and each R 3 is independently selected from the group consisting of C 1-10 hydrocarbyl and C 1-5 alkoxy.
摘要:
A method of forming a compound of formula (IV) comprising the step of reacting a compound of formula (III) with a 2-ethylhexanoate salt: wherein R 1 in each occurrence is independently selected from H, halogen, amino, C 1-5 alkyl, C 2-5 alkenyl and C 2-5 alkynyl; R 2 in each occurrence is independently selected from H, halogen, amino, C 1-5 alkyl, C 2-5 alkenyl and C 2-5 alkynyl; and R 4 is C 1-5 alkyl; X- is an anion and each R 3 is independently selected from the group consisting of C 1-10 hydrocarbyl and C 1-5 alkoxy.
摘要:
The compound of formula (I) is a β-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.
摘要:
Compounds of formula (I), wherein R?1 and R2¿ are each independently hydrogen, (C¿1?-C10)alkyl, (C3-C8)cycloalkyl, (C2-C10)alkenyl, (C2-C10)alkynyl, -COORa, -CONRbRc, cyano, -C(=O)Rd, -ORe, aryl, heteroaryl, oxazolidinyl, isoxazolidinyl, morpholinyl, -S(O)mRf, -NRgRh, azido, or halo; R?3¿ is (C¿3?-C10)alkyl, (C2-C10)alkenyl, (C2-C10)alkynyl, (C1-C10)alkanoyl, (C3-C8)cycloalkyl, aryl, heteroaryl, aryl(C1-C10)alkyl, heteroaryl(C1-C10)alkyl, or -CH2Ri, wherein Ri is halo, cyano, cyanato, -ORj, -NRkRl, azido, -SRm, or (C3-C8)cycloalkyl; R?4¿ is hydrogen, (C¿1?-C10)alkyl, (C3-C8)cycloalkyl, (C2-C10)alkenyl, (C2-C10)alkynyl, aryl, or heteroaryl; m and n are each independently 0, 1, or 2; and their pharmaceutically acceptable salts, are useful for inhibiting β-lactamase enzymes, for enhancing the activity of β-lactam antibiotics, and for treating β-lactam resistant bacterial infections in a mammal. The invention also provides pharmaceutical compositions, processes for preparing compounds of formula (I), and novel intermediates useful for the synthesis of compounds of formula (I).
摘要:
A process for preparing an exo-methylenepenam compound represented by the formula (2) wherein cephem compound represented by the formula (1) is reduced with a metal having a standard oxidation-reduction potential of up to -0.3 (V/SCE) in an amount of at least one mole per mole of the cephem compound and with a metal compound having a higher standard oxidation reduction potential than the metal in an amount of 0.0001 to 10 moles per mole of the cephem compound to obtain the exo-methylenepenam compound wherein R is a hydrogen atom, amino or protected amino, R is a hydrogen atom, halogen atom, etc. R is a hydrogen atom or carboxylic acid protective group, X is a halogen atom, etc. wherein R , R and R are as defined above.d